NRF2 Regulates HER2 and HER3 Signaling Pathway to Modulate Sensitivity to Targeted Immunotherapies

by Hilal S. Khalil, Simon P. Langdon, Ibrahim H. Kankia, James Bown, Yusuf Y. Deeni
Published 2016-01-01

Characterising the tumour morphological response to therapeutic intervention: an ex vivo model

by Anne Savage, Elad Katz, Alistair Eberst, Ruth E. Falconer, Alasdair Houston, David J. Harrison, James Bown
Published 2013-01-01

Systems Analysis of Drug-Induced Receptor Tyrosine Kinase Reprogramming Following Targeted Mono- and Combination Anti-Cancer Therapy

by Alexey Goltsov, Yusuf Deeni, Hilal S. Khalil, Tero Soininen, Stylianos Kyriakidis, Huizhong Hu, Simon P. Langdon, David J. Harrison, James Bown
Published 2014-06-01